Clinical trial
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours…
NCT00180947 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Unknown status
Key facts
| NCT number | NCT00180947 |
|---|---|
| Title | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse |
| Official title | Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhabdomyosarcomas, Neoplasms, Connective and Soft Tissue, Ewing Tumor, Osteosarcomas, Neuroblastomas, Medulloblastomas |
| Intervention type | Drug |
| Interventions | Vinorelbine, cyclofosfamide |
| Enrollment | 210 |
| Start date | Jun 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: